Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00025476.xml
CC BY-NC-ND 4.0 · Endosc Int Open 2018; 06(11): E1322-E1329
DOI: 10.1055/a-0743-5520
DOI: 10.1055/a-0743-5520
Case report
Exclusively endoscopic approach to treating gastric perforation caused by an intragastric balloon: case series and literature review
Further Information
Publication History
submitted 14 June 2018
accepted after revision 31 July 2018
Publication Date:
07 November 2018 (online)
Abstract
Background and study aims Obesity is a serious disease, resulting in significant morbidity and mortality. Intragastric balloons (IGBs) have been in use since the 1980s. After the insertion of an IGB, complications such as migration of the device and even severe gastric perforation can occur, requiring laparoscopic surgery. Here, we report three cases of gastric perforation after IGB insertion. In all three cases, the perforation was successfully repaired through an exclusively endoscopic approach.
-
References
- 1 Allison DB, Downey M, Atkinson RL. et al. Obesity as a disease: A white paper on evidence and arguments commissioned by the council of the obesity society. Obesity 2008; 16: 1161-1177
- 2 Espinet-Coll E, Nebreda-Durán J, Gómez-Valero JA. et al. Current endoscopic techniques in the treatment of obesity. Rev Esp Enfermedades Dig 2012; 104: 72-87
- 3 Kumar N, Sullivan S, Thompson CC. The role of endoscopic therapy in obesity management: Intragastric balloons and aspiration therapy. Diabetes, Metab Syndr Obes Targets Ther 2017; 10: 311-316
- 4 Gyring Nieben O, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1982; 319: 198-199
- 5 Moura D, Oliveira J, De Moura EGH. et al. Effectiveness of intragastric balloon for obesity: A systematic review and meta-analysis based on randomized control trials. Surg Obes Relat Dis 2016; 12: 420-429
- 6 Saber AA, Shoar S, Almadani MW. et al. Efficacy of first-time intragastric balloon in weight loss: a systematic review and meta-analysis of randomized controlled trials. Obes Surg 2017; 27: 277-287
- 7 Ribeiro IB, Gestic MA, Utrini MP. et al. Drain amylase levels may indicate gastrojejunostomy leaks after Roux-en-Y gastric bypass. Arq Gastroenterol 2018; 55: 66-72
- 8 Lerner H, Whang J, Nipper R. Benefit-risk paradigm for clinical trial design of obesity devices: FDA proposal. Surg Endosc 2013; 27: 702-707
- 9 Kumar N, Thompson CC. Endoscopic solutions for weight loss. Curr Opin Gastroenterol 2011; 27: 407-411
- 10 Lee W-J, Lee Y-C, Ser K-H. et al. Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures. Obes Surg 2008; 18: 1119-1125
- 11 Sjöström L, Lindroos A-K, Peltonen M. et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693
- 12 Meek CL, Lewis HB, Reimann F. et al. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones. Peptides 2016; 77: 28-37
- 13 Ribeiro IB, Bernardo WM, Martins C. et al. Colonic stent versus emergency surgery as treatment of malignant colonic obstruction in the palliative setting: a systematic review and meta-analysis. Endosc Int Open 2018; 5: E1-E10
- 14 Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: A population-based analysis. J Am Coll Surg 2004; 199: 543-551
- 15 Kakarla VR, Nandipati K, Lalla M. et al. Are laparoscopic bariatric procedures safe in superobese (BMI ≥50 kg/m2) patients? An NSQIP data analysis. Surg Obes Relat Dis 7: 452-458
- 16 Kumar N, Thompson CC. Endoscopic solutions for weight loss. Curr Opin Gastroenterol 2011; 27: 407-411
- 17 Abu Dayyeh BK, Edmundowicz SA, Jonnalagadda S. et al. Endoscopic bariatric therapies. Gastrointest Endosc 2015; 81: 1073-1086
- 18 Gleysteen JJ. A history of intragastric balloons. Surg Obes Relat Dis 2016; 12: 430-435
- 19 Neto MG, Silva LB, Grecco E. et al. Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases. Surg Obes Relat Dis 2018; 14: 151-159
- 20 Mathus-Vliegen EMH, Tytgat GNJ. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 2005; 61: 19-27
- 21 Madruga NetoAC, Bernardo WM, de Moura DT. et al. The effectiveness of endoscopic gastroplasty for obesity treatment according to FDA thresholds: Systematic review and meta-analysis based on randomized controlled trials. Gastrointest Endosc 2018; 87: AB601
- 22 Bernante P, Francini F, Zangrandi F. et al. Green urine after intragastric balloon placement for the treatment of morbid obesity. Obes Surg 2003; 13: 951-953
- 23 Tate CM, Geliebter A. Intragastric balloon treatment for obesity: review of recent studies. Adv Ther 2017; 34: 1859-1875
- 24 Genco A, Cipriano M, Bacci V. et al. BioEnterics® Intragastric Balloon (BIB®): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes 2006; 30: 129-133
- 25 Ponce J, Woodman G, Swain J. et al. The REDUCE pivotal trial: A prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis 2015; 11: 874-881
- 26 Fuller NR, Pearson S, Lau NS. et al. An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study. Obesity 2013; 21: 1561-1570
- 27 Abu Dayyeh BK, Eaton LL, Woodman G. et al. 444 A randomized, multi-center study to evaluate the safety and effectiveness of an intragastric balloon as an adjunct to a behavioral modification program, in comparison with a behavioral modification program alone in the weight management of obese subjects. Gastrointest Endosc 2015; 81: AB147
- 28 Mohammed MA, Anwar R, Mansour AH. et al. Effects of intragastric balloon versus conservative therapy on appetite regulatory hormones in obese subjects. Trends Med Res 2014; 9: 58-80
- 29 Sullivan S, Swain JM, Woodman G. et al. The obalon swallowable 6-month balloon system is more effective than moderate intensity lifestyle therapy alone: Results from a 6-month randomized sham controlled trial. Gastroenterology 2016; 150: S1267
- 30 Ribeiro IB, Rezende DT, Madruga NetoAC. et al. Endoscopic dual therapy for giant peptic ulcer hemorrhage. Endoscopy 2018; DOI: 10.1055/a-0665-4142. [Epub ahead of print]
- 31 Genco A, Bruni T, Doldi SB. et al. BioEnterics intragastric balloon: The Italian experience with 2,515 patients. Obes Surg 2005; 15: 1161-1164
- 32 Dayan D, Sagie B, Fishman S. Late Intragastric Balloon Induced Gastric Perforation. Obes Surg 2016; 26: 1138-1140
- 33 Roche-Nagle G, Mulligan E, Connolly E. et al. Unusual cause of a perforated stomach. Ann R Coll Surg Engl 2003; 85: 396-397
- 34 Bekheit M, Abdelsalam WN, Sgromo B. et al. Is conservative management for gastric perforation secondary to intragastric balloon possible? Case report and review of literature. Obes Surg 2014; 24: 968-970
- 35 Giardiello C, Cristiano S, Cerbone MR. et al. Gastric perforation in an obese patient with an intragastric balloon, following previous fundoplication. Obes Surg 2003; 13: 658-660
- 36 Koutelidakis I, Dragoumis D, Papaziogas B. et al. Gastric perforation and death after the insertion of an intragastric balloon. Obes Surg 2009; 19: 393-396
- 37 Smigielski JA, Szewczyk T, Modzelewski B. et al. Gastric perforation as a complication after BioEnterics intragastric balloon bariatric treatment in obese patients – synergy of endoscopy and videosurgery. Obes Surg 2010; 20: 1597-1599
- 38 Knoetze R, van Mollendorff V, Yuen O. Gastric perforation as a complication of an intragastric balloon. Continuing Medical Education 2010; 28: 392
- 39 Baigel R, Rashid F, Shrestha D. et al. Peritonitis following a bariatric procedure in a young woman. BMJ Case Rep 2011 Feb 2011; 14
- 40 Sánchez-Pérez MA, Muñoz-Juárez M, Cordera-González De Cosío F. et al. Gastric perforation and subarachnoid hemorrhage secondary to intragastric balloon device. Rev Gastroenterol Mex 2011; 76: 264-269
- 41 Charalambous MP, Thompson J, Efthimiou E. Late gastric perforation after insertion of intragastric balloon for weight lossvideo case report and literature review. Surg Obes Relat Dis 2012; 8: 121-123
- 42 El Hage Chehade HH, El Khatib ZO, Abtar HK. What could happen if you insert a BioEnterics intragastric balloon after sleeve gastrectomy?. Surg Obes Relat Dis 2015; 11: e39-e41
- 43 Abou Hussein BM, Khammas AA, Al Ani AM. et al. Gastric perforation following intragastric balloon insertion: combined endoscopic and laparoscopic approach for management: case series and review of literature. Obes Surg 2016; 26: 1127-1132
- 44 Yoo IK, Chun HJ, Jeen YT. Gastric perforation caused by an intragastric balloon: endoscopic findings. Clin Endosc 2017; 50: 602-604
- 45 Rahman AA, Loi K. Gastric perforation as a complication of intragastric balloon. Surg Obes Relat Dis 2018; 1-4